The legacy success of sildenafil has undeniably transformed the healthcare landscape. However, putting money in companies heavily dependent on biosimilars and the diminishing patent protection surrounding https://rotatesites.com/story22913037/viagra-and-pharmaceutical-companies-a-risky-opportunity